TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 336 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q4 2019. The put-call ratio across all filers is 1.03 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $33,000 | +3.1% | 2,335 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $32,000 | -15.8% | 2,335 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $38,000 | -2.6% | 2,335 | 0.0% | 0.00% | -50.0% |
| Q2 2021 | $39,000 | -9.3% | 2,335 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $43,000 | +2.4% | 2,335 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $42,000 | 0.0% | 2,335 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $42,000 | 0.0% | 2,335 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $42,000 | +20.0% | 2,335 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $35,000 | -23.9% | 2,335 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $46,000 | +7.0% | 2,335 | -5.8% | 0.00% | 0.0% |
| Q3 2019 | $43,000 | +4.9% | 2,480 | +6.2% | 0.00% | 0.0% |
| Q2 2019 | $41,000 | -14.6% | 2,335 | 0.0% | 0.00% | -33.3% |
| Q1 2019 | $48,000 | – | 2,335 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Adelphi Capital LLP | 9,270,535 | $188,841,000 | 39.13% |
| Sachem Head Capital | 5,963,600 | $121,479,000 | 7.38% |
| NINE MASTS CAPITAL Ltd | 1,049,886 | $21,415,000 | 6.68% |
| Paulson & Co. | 26,489,422 | $539,590,000 | 5.77% |
| Blackcrane Capital, LLC | 189,549 | $3,861,000 | 5.16% |
| Glenview Capital Management | 26,112,660 | $531,915,000 | 4.75% |
| Exane Asset Management | 430,369 | $8,766,617,000 | 4.26% |
| Velanne Asset Management Ltd | 281,972 | $5,744,000 | 3.97% |
| Bluefin Trading, LLC | 1,204,702 | $24,540,000 | 3.55% |
| Endurant Capital Management LP | 437,436 | $8,911,000 | 3.52% |